FDA Releases Draft Guidance for Electro-Optical Sensors in Cervical Cancer Detection

Summary

The FDA has made available a draft guidance for industry on electro-optical sensors for in vivo detection of cervical cancer and its precursors, outlining the requirements for an IDE/PMA application and the potential for these devices to complement or replace existing screening methods.